JP2016500260A5 - - Google Patents

Download PDF

Info

Publication number
JP2016500260A5
JP2016500260A5 JP2015547149A JP2015547149A JP2016500260A5 JP 2016500260 A5 JP2016500260 A5 JP 2016500260A5 JP 2015547149 A JP2015547149 A JP 2015547149A JP 2015547149 A JP2015547149 A JP 2015547149A JP 2016500260 A5 JP2016500260 A5 JP 2016500260A5
Authority
JP
Japan
Prior art keywords
cell
cells
gene
tet3
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015547149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500260A (ja
Filing date
Publication date
Priority claimed from GBGB1222693.2A external-priority patent/GB201222693D0/en
Application filed filed Critical
Publication of JP2016500260A publication Critical patent/JP2016500260A/ja
Publication of JP2016500260A5 publication Critical patent/JP2016500260A5/ja
Pending legal-status Critical Current

Links

JP2015547149A 2012-12-17 2013-12-17 新規方法 Pending JP2016500260A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1222693.2A GB201222693D0 (en) 2012-12-17 2012-12-17 Novel method
GB1222693.2 2012-12-17
PCT/GB2013/053317 WO2014096800A1 (en) 2012-12-17 2013-12-17 Novel method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018218938A Division JP2019058176A (ja) 2012-12-17 2018-11-22 新規方法

Publications (2)

Publication Number Publication Date
JP2016500260A JP2016500260A (ja) 2016-01-12
JP2016500260A5 true JP2016500260A5 (enExample) 2017-02-02

Family

ID=47630838

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015547149A Pending JP2016500260A (ja) 2012-12-17 2013-12-17 新規方法
JP2018218938A Pending JP2019058176A (ja) 2012-12-17 2018-11-22 新規方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018218938A Pending JP2019058176A (ja) 2012-12-17 2018-11-22 新規方法

Country Status (8)

Country Link
US (2) US20160186207A1 (enExample)
EP (1) EP2931881A1 (enExample)
JP (2) JP2016500260A (enExample)
CN (1) CN105051188A (enExample)
AU (1) AU2013366092A1 (enExample)
CA (1) CA2894822A1 (enExample)
GB (1) GB201222693D0 (enExample)
WO (1) WO2014096800A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010037001A2 (en) 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
HK1198547A1 (en) 2011-07-29 2015-05-15 剑桥表现遗传学有限公司 Methods for detection of nucleotide modification
WO2014083118A1 (en) 2012-11-30 2014-06-05 Cambridge Epigenetix Limited Oxidising agent for modified nucleotides
GB201403216D0 (en) 2014-02-24 2014-04-09 Cambridge Epigenetix Ltd Nucleic acid sample preparation
CN104630272A (zh) * 2015-01-06 2015-05-20 西北农林科技大学 一种基于去甲基化促进生殖干细胞自我更新和增殖的载体及其应用
BR112018011089A2 (pt) 2015-12-04 2018-12-04 Intellia Therapeutics Inc composições e métodos para a imuno-oncologia
US20200087629A1 (en) * 2016-10-19 2020-03-19 Fred Hutchinson Cancer Research Center Compositions and methods for reprogramming cells and for somatic cell nuclear transfer using duxc expression
JP2020513832A (ja) 2017-03-22 2020-05-21 ノバルティス アーゲー 免疫腫瘍学のための組成物および方法
SG11201909866VA (en) * 2017-05-29 2019-11-28 Agency Science Tech & Res Markers of totipotency and methods of use
WO2019164876A1 (en) * 2018-02-20 2019-08-29 The Regents Of The University Of California Therapeutics that invoke epigenetic changes for use in treating neurological conditions such as cognitive impairment
WO2020028617A1 (en) * 2018-08-01 2020-02-06 University Of Georgia Research Foundation, Inc. Compositions and methods for improving embryo development

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007069666A1 (ja) * 2005-12-13 2007-06-21 Kyoto University 核初期化因子
WO2010037001A2 (en) * 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins

Similar Documents

Publication Publication Date Title
JP2016500260A5 (enExample)
JP2018508198A5 (enExample)
JP2018520654A5 (enExample)
HK1248279A1 (zh) 补充牛磺酸的细胞培养基和使用方法
HRP20211882T1 (hr) Protutijela protiv cd40 i njihova upotreba
PH12017502424A1 (en) Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
JP2015506673A5 (enExample)
EA201401319A1 (ru) Способы и композиции рнк-специфической модификации днк-мишении рнк-специфической модуляции транскрипции
JP2016501515A5 (enExample)
JP2011525793A5 (enExample)
MX382822B (es) Metodos y productos para transfeccion de celulas.
JP2014533491A5 (enExample)
JP2017131682A5 (enExample)
JP2016539641A5 (enExample)
MX2013005140A (es) Medios de cultivo de celulas granulados en seco.
MX2021009554A (es) Produccion de virus en cultivos celulares.
MX2018015234A (es) Métodos para mejorar la transformación genética de sorgo.
MX380687B (es) Metodo para preparar células troncales con pluripotencia inducida a partir de células troncales mesenquimatosas utilizando una fracción de florotanino.
WO2020077347A3 (en) Compositions and methods for transfecting cells
JP2016510766A5 (enExample)
MX2021001981A (es) Metodos para preparar un poloxamero para usar en medio de cultivo celular.
JP2010166901A5 (enExample)
JP2016063801A5 (enExample)
WO2016069518A3 (en) Genetically stable replication competent sendai virus vector(s) containing and expressing optimized hiv genes
WO2015117033A3 (en) Methods of increasing protein production in mammalian cells